<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083650</url>
  </required_header>
  <id_info>
    <org_study_id>MAM CONDE</org_study_id>
    <nct_id>NCT05083650</nct_id>
  </id_info>
  <brief_title>Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis</brief_title>
  <official_title>Comparison of Macular Hole Closure Rate in Patients With Poor Prognosis Clinical Features Treated With Amniotic Membrane Graft With and Without Limitorrhexis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Oftalmología Fundación Conde de Valenciana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Oftalmología Fundación Conde de Valenciana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with idiopathic macular holes (MHs) postoperative closure rates for large MHs&#xD;
      (diameter &gt; 550 μm) are disappointing and often require a second intervention, different&#xD;
      techniques have been described with very variable success rates in different published&#xD;
      studies, an efficient technique with good functional outcome has not been found.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional study in large macular holes (diameter &gt; 550 μm) using an amniotic membrane&#xD;
      with and without internal limiting membrane peeling.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">March 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Large MHs (diameter &gt; 550 μm)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>We never let the patient know the performed surgery</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>% of macular hole clousure measured with OCT</measure>
    <time_frame>6 months</time_frame>
    <description>Closure of the macular hole by optical coherence tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best-corrected visual acuity measured with Snellen Chart</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement of 2 lines in best-corrected visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superficial and deep retinal capillary plexus density with OCT-A</measure>
    <time_frame>6 months</time_frame>
    <description>Presence of capillary plexus in macular hole area</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>Amniotic membrane without internal limiting membrane peeling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The surgery performed will be phacoemulsification + vitrectomy using an amniotic membrane to plug the macular hole using air as tamponade.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amniotic membrane with internal limiting membrane peeling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The surgery performed will be phacoemulsification + vitrectomy + internal limiting membrane peeling using an amniotic membrane to plug the macular hole using air as tamponade.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Macular hole closure with amniotic membrane with/without internal limiting membrane peeling</intervention_name>
    <description>Pars plana vitrectomy with/without internal limiting membrane peeling, amniotic membrane, and air tamponade</description>
    <arm_group_label>Amniotic membrane with internal limiting membrane peeling</arm_group_label>
    <arm_group_label>Amniotic membrane without internal limiting membrane peeling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Not myopic patients (&lt;6 Dioptre or &lt;26 mm)&#xD;
&#xD;
          -  Large macular hole &gt;550 μm&#xD;
&#xD;
          -  &gt; 6 months symptoms&#xD;
&#xD;
          -  Signing informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with other ocular disease (diabetic retinopathy, glaucoma, uveitis, ocular&#xD;
             tumors, etc)&#xD;
&#xD;
          -  Using systemic drugs that are toxic for the optic nerve or retina (chloroquine,&#xD;
             hydroxychloroquine, tamoxifen, ethambutol, etc)&#xD;
&#xD;
          -  Patients with ocular surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Rios Esquer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ishtar A Astorga Carballo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose L Rodriguez Loaiza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zita Chao Loyo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Esparza Correa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zita Chao Loyo, MD</last_name>
    <phone>+52 33994182</phone>
    <email>investigacionretinaconval@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto de Oftalmologia Conde de Valenciana</name>
      <address>
        <city>Ciudad de Mexico</city>
        <zip>06800</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Rodriguez Loaiza, MD</last_name>
      <phone>+52 5554123012</phone>
      <email>jose.rodriguez@institutodeoftalmologia.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Oftalmología Fundación Conde de Valenciana</investigator_affiliation>
    <investigator_full_name>Jose Luis Rodriguez Loaiza</investigator_full_name>
    <investigator_title>Medical Subdirector</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

